The U.S. health officials have recommended a pause in the use of French biotech Valneva’s (NASDAQ:VALN) chikungunya vaccine ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug Association (FDA) and the U.S. Centers for Disease Control and Prevention (CDC) ...

The European Union's health regulator said on Wednesday it was reviewing French drugmaker Valneva's chikungunya vaccine after ...

Matthew Herper joins Adam and Allison to examine Prasad’s appointment and the band of outsiders now in charge of U.S. health ...

Bavarian Nordic is successfully navigating a sentiment-changing vaccine landscape, posting Q1 revenues significantly up from ...

Valneva SE offers exposure to a robust travel vaccine portfolio that includes Ixiaro, Dukoral, and Ixchiq. Read what ...

The advisory panel to the Centers for Disease Control and Prevention had made recommendations regarding the use of separate ...

Columbia University and NewYork-Presbyterian Hospital agreed to pay $750 million to settle hundreds of sexual abuse claims ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Bavarian Nordic’s Vimkunya (recombinant, adsorbed ...

We also recorded our first US sales of the chikungunya vaccine after its approval in February and ahead of the April recommendation from ACIP. Our phased launch plan for the vaccine is progressing ...

Europe Reviews Valneva's Chikungunya Vaccine After Reports of Serious Side Effects (Reuters) -The European Union's health regulator said on Wednesday it was reviewing French drugmaker Valneva's ...

May 7 (Reuters) - The European Union's health regulator said on Wednesday it was reviewing French drugmaker Valneva's (VLS.PA), opens new tab chikungunya vaccine after reports of serious side ...